Eton Pharmaceuticals (ETON) Market Capitalization (2018 - 2026)

Eton Pharmaceuticals has disclosed Market Capitalization across 9 years of filings, most recently posting $1.0 billion for Q2 2026.

• In Q2 2026, Market Capitalization rose 167.98% year-over-year to $1.0 billion; the TTM figure through Jun 2026 stood at $1.0 billion (up 167.98% YoY), while the FY2025 annual figure was $457.4 million, up 28.56% from the prior year.
• Market Capitalization came in at $1.0 billion for Q2 2026 at Eton Pharmaceuticals, up from $457.4 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $1.0 billion in Q2 2026 to a low of $53.1 million in Q3 2022.
• Average Market Capitalization over 5 years is $246.6 million, with a median of $107.4 million recorded in 2022.
• Year-over-year, Market Capitalization sank 57.16% in 2022 and soared 351.16% in 2025.
• Over 5 years, Market Capitalization stood at $71.5 million in 2022, then jumped by 57.37% to $112.5 million in 2023, then surged by 216.2% to $355.8 million in 2024, then advanced by 28.56% to $457.4 million in 2025, then soared by 123.91% to $1.0 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $1.0 billion in Q2 2026, $457.4 million in Q4 2025, and $582.7 million in Q3 2025.